Abstract-The microsomal triglyceride transfer protein (MTP) plays a key role in the assembly of apolipoprotein B (apoB)-containing lipoproteins. We investigated the relation between lipid profiles and a common functional polymorphism (Ϫ493G/T) of the MTP gene in a large sample of young black men in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. We performed serial cross-sectional analyses on lipids of 586 black men in 5 exams over 10 years of follow-up. Total cholesterol, LDL cholesterol, and apoB levels were very similar between the GT and GG genotypes; therefore, the GT and GG genotypes were combined as 1 group when the 3 phenotypes were analyzed. The results from ANCOVA showed that the TT group (prevalence 7%) had higher levels of apoB-related lipids than did the GTϩGG group: the difference in total cholesterol ranged from 2 (Pϭ0.79) to 19 (Pϭ0.002) mg/dL in exams 1 to 5; the difference in LDL cholesterol ranged from 10 (Pϭ0.14) to 17 (Pϭ0.003) mg/dL in exams 1 to 4, but in examination 5, the difference became negligible. The TT group had higher levels of apoB, measured in only 2 exams, by 6 (Pϭ0.12) and 9 (Pϭ0.03) mg/dL. The TT group had higher levels of triglycerides than did the TG or GG group by 3 to 34 (Pϭ0.02 to Ϸ0.003) mg/dL in all 5 exams. HDL cholesterol and apolipoprotein A-I levels were similar among the 3 genotypes. Our serial cross-sectional analyses indicated that the TT genotype was associated with higher levels of total cholesterol, LDL cholesterol, triglycerides, and apoB in young black men. The broad effect of this polymorphism on several atherogenic traits suggests that the MTP gene could be influential in atherosclerosis. Key Words: polymorphism Ⅲ microsomal triglyceride transfer proteins Ⅲ lipoproteins Ⅲ apolipoproteins E pidemiological studies have revealed that high concentrations of plasma cholesterol, 1,2 apoB, 3,4 and triglycerides 5,6 are risk factors for coronary artery disease. These atherogenic lipid phenotypes are mainly involved in the metabolism of VLDL and LDL. A great deal of research effort has been focused on the determinants of these risk factors. Currently, it is generally believed that genetic factors 7,8 as well as environmental factors, such as diet, 2,9,10 smoking, 11 and exercise, 12 are involved in determining the plasma concentrations of these lipid phenotypes.
inhibited, the secretion of apoB is dramatically reduced. 22, 23 The human MTP gene is Ϸ55 kb in length and is located on chromosome 4. Recently, a common polymorphism (Ϫ493 G/T) in the promoter of the MTP gene was reported to have an association with LDL-C and LDL triglycerides in healthy, middle-aged, white Swedish men. 24 Two linkage studies also found evidence of linkage between the MTP gene and LDL-C 25 and triglyceride 26 levels. Functional studies have suggested that this polymorphism (Ϫ493 G/T) may regulate the transcriptional activity by influencing allele-specific binding of nuclear proteins. 24 We conducted a study with a large cohort from the Coronary Artery Risk Development in Young Adults (CAR-DIA) Study to investigate the prevalence and effect of this polymorphism on lipid levels in 5 consecutive exams in healthy young African American men. In this cohort, DNA samples were available from 586 African American men who had complete lipid measurements from 5 consecutive exams (year 0, 1985 to 1986; year 2, 1987 to 1988; year 5, 1990 to 1991; year 7, 1992 to 1993; and year 10, 1995 to 1996) .
Methods
The present study was approved by the Institutional Review Boards at the Rockefeller University and 4 CARDIA participating centers (Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California centers).
Subjects
The details of the CARDIA Study are described elsewhere. 27 In brief, the CARDIA Study is a multicenter, longitudinal study on lifestyle and evolution of cardiovascular disease risk factors in young adults aged 18 to 30 years at initial examination (1985 to 1986). Participants were randomly recruited from the total community or from selected census tracts in the community for the centers in Birmingham, Chicago, and Minneapolis. For the center in Oakland, participants were randomly recruited from the Kaiser-Permanente health plan membership. Study subjects received examinations and questionnaires every 2 to 3 years. To test the present hypothesis, we used the data from black men in the CARDIA cohort. Five hundred eighty-six black men who had participated in all 5 examinations over a 10-year follow-up had available DNA samples. Various individuals were further excluded in the analyses because they did not fast 8 hours before drawing the blood (17 individuals in year 0, 59 in year 2, 53 in year 5, 64 in year 7, and 46 in year 10).
Lipoprotein Measurements
Venous blood was drawn after a 12-hour fast. Total cholesterol and total triglyceride levels were enzymatically determined. 28 LDL-C was estimated by using the Friedewald equation: LDL-Cϭtotal cholesterolϪHDL-CϪ(triglyceride/5), where HDL-C indicates HDL cholesterol. 29 Subjects with triglyceride levels Ն400 mg/dL did not have calculable LDL-C; thus, their LDL-C levels were not included in the analyses. HDL-C was measured enzymatically after dextran sulfate-magnesium precipitation of apoB-containing particles. 30, 31 ApoA-I 32 and apoB 33 were analyzed by radioimmunoassay. Lipid data for year 2 were systematically elevated because of laboratory drift, and we performed analyses on data with and without adjustment for this effect.
Assay of MTP Polymorphism
DNA was isolated from whole blood samples. The method for detecting the Ϫ493 G/T polymorphism was adapted from Karpe et al. 24 A 109-bp DNA product, encompassing the Ϫ493 site, was generated by polymerase chain reaction with a 5Ј mismatched primer (5Ј-GGA TTT AAA TTT AAA CTG TTA ATT CAT ATC AC) and a 3Ј primer (5Ј-AGT TTC ACA CAT AAG GAC AAT CAT CTA). The polymerase chain reaction was performed in 11 L of 10 mmol/L Tris-HCl (pH 9.0 at 25°C), 50 mmol/L KCl, 4 mmol/L MgCl 2 , 0.1% Triton X-100, 240 mol/L dNTPs, 1 L genomic DNA, 12.5 pmol of each primer, and 0.5 U of Taq polymerase. The reaction was carried out first by denaturing at 94°C for 4 minutes, then by 35 rounds of denaturing for 30 seconds at 94°C, annealing at 55°C for 45 seconds, and elongating for 30 seconds at 72°C, and then by a final elongation step of 72°C for 7 minutes. HphI (0.5 L, 2.5 U) plus 1 L of 10ϫ Buffer 4 (New England Biolabs) was subsequently added into the mix. After 4 hours of incubation at 37°C, the product was run on 4% agarose gel. A "G" at position Ϫ493 yielded bands of 89 and 20 bp, whereas a "T" at position Ϫ493 yielded a band of 109 bp.
Measurement of Other Covariates
Several factors can influence lipid levels, and they have been collected in the CARDIA Study. We also investigated the distribution of demographic characteristics among 3 genotypes. These data included age, body mass index (BMI), education, alcohol consumption, 34 smoking history, 34 total physical activity scores, 35 calories, 36 dietary total saturated fatty acids and polyunsaturated fatty acids, 36, 37 and Keys scores. 37, 38 The details of the measurements of the demographic data were described elsewhere. In brief, age, years of education, alcohol intake, and smoking history were ascertained by a self-administered questionnaire. Body weight was measured while subjects wore light clothing, and height was measured without shoes. BMI was calculated as weight (in kilograms) divided by height squared (square meters). Physical activity was measured by use of a physical activity history questionnaire, and a total physical activity score was based on moderate and intense exercise in the previous year. Dietary intake data were obtained from a detailed diet-history questionnaire. Total calories and fat were estimated from the diet-history questionnaire. The Keys score was calculated by using the following formula: 1.35(2SϪP)ϩ1.5Z, where S is the percentage of dietary calories from saturated fatty acids, P is the percentage of dietary calories from polyunsaturated fatty acids, and Z is the square root of dietary cholesterol in milligrams per 1000 kilocalories. This formula, derived by Keys et al, 9 was based on data from a serial of metabolic ward studies to estimate the combined effect of these dietary factors on serum cholesterol.
Statistical Methods
Allele frequencies were estimated by direct gene counting. HardyWeinberg equilibrium was tested by the x 2 test. We first used ANCOVA to test for the overall significant differences of lipids and baseline characteristics among the 3 genotypes, with adjustment for the differences in data from the 4 participating centers. Second, pairwise comparisons between any 2 of the 3 genotypes were tested by using the Scheffé method to adjust for multiple comparisons to determine the mode of the genetic effect. Third, covariates including age, BMI, alcohol consumption, smoking history, total physical activity scores, and Keys scores were further taken into account in evaluating genetic effects. Because the data were available for 5 consecutive exams, we conducted the above statistical tests for each examination to see whether the genetic effect was consistently significant throughout the follow-up period.
To reduce skewness and kurtosis, triglyceride levels were logarithmically transformed, but untransformed means are presented in the tables. SAS software (SAS Institute Inc) was used for all statistical analyses. A value of PϽ0.05 (by 2-tailed test) was considered statistically significant.
Results

Comparison of Baseline Characteristics
The baseline characteristics of the participants among 3 genotypes are provided in Table 1 . Except for education and smoking history, which were of borderline significance, there were no significant differences in mean age, BMI, alcohol consumption, physical activity scores, dietary total saturated fatty acids, dietary polyunsaturated fatty acids, or Keys scores among 3 genotypes in the year-0 examination.
Allele Frequency
DNA samples were available from 586 individuals, and 579 individuals were successfully genotyped. There were 304, 236, and 39 individuals with genotypes GG, GT, and TT (Table 1) , respectively, and the T allele frequency was 0.27. The distribution of genotypes was not significantly different from the expectation under the Hardy-Weinberg equilibrium (Pϭ0.75). The allele and genotype frequencies in African American men were similar to those in healthy middle-aged white men. 24 
Effects of MTP Genotypes on Lipids and Apolipoproteins
Mean total cholesterol, LDL-C, and apoB levels in the TT genotype group were consistently higher than those in either the GT or GG genotype groups in any of the 5 exams, except for LDL-C in year 10 (Table 2 ; note that apoB levels were available only for the first 2 exams). The mean plasma levels were very similar between GT and GG genotypes for these 3 lipids. Thus, the T allele fits a recessive model, and the data in the GT and GG genotypes were pooled in the following analyses. Table 3 shows pooled data for total cholesterol, LDL-C, and apoB, adjusting for the center effect. The difference between the TT and GGϩGT genotypes was significant (or marginally significant) in the first 4 exams but not significant in the year-10 examination. By and large, the results changed only slightly (Table 4 ) after additional adjustment for age and BMI. When more covariates (smoking, alcohol drinking, physical activity, and Keys scores) were taken into account, the results showed patterns similar to those in Table 4 (data not shown). The results remained the same when we adjusted for laboratory drift in year 2. All values from year 2 in the present study do not account for laboratory drift.
For triglyceride levels, which have a large biological variation, the TT genotype still had consistently higher mean levels than did the other 2 genotypes (Table 2 ). However, the T allele does not fit a recessive model. A significant genetic effect was noticed in all exams (Tables 2 and 5 ) regardless of adjustment for the center effect, age, and BMI, although an additive genetic effect was not observed. When smoking history, daily alcohol intake, and physical activity were also taken into account, the results remained similar (data not shown). There were no differences in HDL-C or apoA-I levels among the 3 genotypes (Table 2) .
Discussion
This is the first study to investigate the serial cross-sectional data over 10 years of the genetic effect of the MTP polymorphism on lipid profiles in young African American men. The GT and GG subjects had similar mean lipid levels of total cholesterol, LDL-C, and apoB. Accordingly, the effect of the T allele appears to be recessive in elevating lipid levels. The TT genotype was constantly associated with higher mean levels of total cholesterol, LDL-C, apoB, and triglycerides in every examination (except for LDL-C in the year-10 examination). The varied probability values seen in each examination could result from the relatively small number of the TT individuals. If we had analyzed only year-0 data, we could have made a conclusion of no genetic effect on apoB-related phenotypes. Therefore, the present study highlighted the importance of using serial measurements to investigate genes with moderate effects. Total cholesterol and LDL-C in the year-10 examination were not different between the TT and GGϩGT genotypes, which could be caused by random variation due to the small sample size of the TT individuals or a decrease of the genetic effect with age. We have performed a longitudinal analysis by the generalized estimating equation method, 39, 40 and the result indicated that the trends of annual change in total cholesterol and LDL-C were significantly different among genotypes (data not shown). Although this result could indicate geneϫenvironment interaction, we suspect that this result was primarily biased by the significant drop of cholesterol levels in the TT group in year 10. Therefore, no conclusion can be drawn from the longitudinal analysis. Although triglyceride levels between GG and GT individuals did not show a consistent pattern, the TT individuals were clearly associated with a higher level in all of the 5 exams. It needs to be noted that the standard error for triglyceride levels steadily increased in consecutive measures, which was not seen in other lipids. The increased variation in triglyceride levels over time might partially explain the less consistent association among 3 genotypes. Alternatively, molecular heterosis, which refers to the presence of a lesser or greater phenotypic effect in heterozygotes than in homozygotes, may explain the lowest triglyceride means in the GT individuals. Although molecular heterosis has been studied extensively in corn, it has been reported in only a few human genes. 41, 42 The Ϫ493 G/T MTP polymorphism is assumed to influence the production of apoB-containing particles. We have found that total cholesterol, LDL-C, apoB, and triglycerides, which are mainly from the VLDL-LDL metabolic pathway, were all influenced by this polymorphism. On the contrary, HDL-C and apoA-I, which are not directly derived from the production of VLDL, were similar among the 3 genotypes. Although epidemiological studies have demonstrated an inverse relation between HDL-C and triglyceride levels, 43 our results did not show any significant difference in HDL-C levels among genotypes. Whether triglyceride levels in the TT genotype were not high enough to influence HDL-C levels or whether an unknown metabolic adjustment in the TT genotype led to the lack of an inverse relation between triglyceride and HDL-C requires further investigation.
MTP expression can greatly enhance the process of apoBcontaining lipoprotein formation and also decrease apoB degradation in the ER lumen. 21 MTP appears to control the number of apoB-containing lipoprotein particles secreted rather than their lipid composition. 21 Karpe et al 24 have performed expression studies showing that the T allele has an almost 2-fold higher transcriptional activity than does the G allele. This might suggest that individuals with the TT genotype have a higher production rate of apoB-containing lipoproteins. It would be a reasonable hypothesis to test for increasing levels of components in apoB-containing lipoproteins in individuals with the TT genotype. Furthermore, given only 1 apoB molecule in each VLDL and LDL particle, we would expect to see a compatible increase in apoB and in lipids carried mainly by apoB-containing particles. Indeed, our results support this hypothesis. ApoB and LDL-C were Ϸ9% (in year 0) and 11% (in year 2) higher in the TT genotype than in the GGϩGT genotype (Table 3) . This finding offers further support for the association between this polymorphism and lipid profiles.
It should be noted that the increase of apoB-related lipids in the TT individuals is not as striking as what was observed in the expression studies, suggesting that the TT genotype could have 2-fold higher transcriptional activity than the GG genotype. 24 The apoB gene is constitutively expressed 44 ; thus, the rate of synthesis of apoB remains constant. ApoB is rapidly degraded in the ER before secretion if a nascent apoB molecule does not acquire sufficient lipid. 45, 46 Therefore, the secretion of apoB and apoB-containing lipoprotein from the liver depends on the balance between degradation and lipoprotein assembly. 44, 47 Several studies have indicated that MTP transfers lipid to Values are meanϮSE. The GG and GT genotypes were pooled, assuming a recessive model for the T allele.
apoB and stabilizes nascent apoB polypeptides in the ER. 22, 48, 49 Thus, although the T allele has 2-fold higher transcriptional activity in transfected cells, the availability of apoB polypeptides in the ER could restrict the production of apoB-containing lipoprotein. Accordingly, the increased levels of plasma apoB-containing lipoprotein could be disproportional to the increased levels of MTP. Alternatively, there might be posttranscriptional modification to metabolize overproduced apoB-containing lipoprotein in the TT individuals. However, further studies are necessary to clarify this point. Abetalipoproteinemia is a rare autosomal recessive disease caused by mutations in the MTP gene leading to undetectable MTP activity. 50, 51 Subjects have only trace levels of apoBcontaining lipoproteins. Therefore, MTP activity should reflect levels of apoB-containing lipoproteins. In the present study, the TT individuals had a higher level of apoBcontaining lipoproteins, which is in concert with the expression study by Karpe et al. 24 However, Karpe et There are some potentially important differences between the 2 studies, such as sample sizes, race, age, BMI, and other environmental factors. Our sample size was Ͼ3-fold larger than theirs (579 versus 184). Our population consisted of young black men, and their study consisted of middle-aged white men. In addition, our population had a higher BMI than theirs. Other environmental factors, such as diet, could also contribute to the discrepancies between these 2 studies. Unfortunately, no dietary information was provided by Karpe et al. Although the TT individuals were almost always associated with a higher level of apoB-containing lipoproteins in our 5 consecutive measurements, total cholesterol and LDL-C levels from the year-10 examination were similar among the 3 genotypes. Whether the substantial decrease of cholesterol in the TT genotype in the year-10 examination will continue and result in an opposite association between the TT genotype and lipid levels or whether it was merely due to a random variation requires further follow-up. Herrmann et al 52 reported no association between another polymorphism at Ϫ400 (A/T) and lipid profiles in 728 white men aged 25 to 64 years. Karpe et al also found this Ϫ400 A/T polymorphism, but they reported that this Ϫ400 polymorphism was not a functional polymorphism. Furthermore, these 2 polymorphisms are not in complete linkage disequilibrium. 24 If a tested locus is not in complete linkage disequilibrium with a causative locus, the power to detect association under this circumstance will be substantially reduced. 53 Therefore, the nonsignificant results from the study of Herrmann et al might be due to this situation. On the other hand, whether the study of Herrmann et al can be explained by the loss of a lipid-raising effect in the older TT individuals remains unanswered. Future studies to investigate the age and racial effects and other possible modifying factors, such as another functional mutation in linkage disequilibrium with this polymorphism, may answer this question.
In summary, the present study found that the TT genotype in young African American men was associated with a higher mean level of apoB-related lipids. The T allele appears to be recessive in raising total cholesterol, LDL-C, and apoB levels, given that the GG and GT genotypes had similar mean levels. The genetic effect of the Ϫ493 G/T MTP polymorphism on several atherogenic lipids suggests that this polymorphism could have profound effects on cardiovascular risks and could be important in understanding the genetics of atherosclerosis. 
